Company profile

SunRegen Healthcare AG

Gewerbestrasse 24
4123 Allschwil
Switzerland
Biotechnology
Ophthalmology Neuroprotection
Pharmaceuticals
Biotech

SunRegen Healthcare is a late stage preclinical biotechnology company that is pioneering the development of novel therapeutics for the treatment of neurodegenerative conditions of the eye. Many of these conditions are significantly unmet, with patients suffering loss of vision and potentially blindness. Our lead indication is Retinitis Pigmentosa, a rare and orphan retinal disease with few treatment options.

 

Contact

Mark Freedman
Mark Freedman
CEO

SWISS Pavilion participations (starting 2019)

Share

Official program